MARKET

SMFRW

SMFRW

Sema4 Holdings Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.550
+0.080
+3.24%
Closed 16:00 09/24 EDT
OPEN
2.470
PREV CLOSE
2.470
HIGH
2.560
LOW
2.470
VOLUME
16.87K
TURNOVER
--
52 WEEK HIGH
12.00
52 WEEK LOW
1.400
MARKET CAP
--
P/E (TTM)
-728.5714
1D
5D
1M
3M
1Y
5Y
Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer
Sema4 Chief Science Officer Gustavo Stolovitzky Gustavo Stolovitzky Joins Sema4 STAMFORD, Conn., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sema4, an AI-driven genomic and clinical data intelligence platform company, today announced the appointment of Gustavo Stol...
GlobeNewswire · 09/13 12:00
Sema4 Launches Sema4 Elements™, a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health
STAMFORD, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sema4, an AI-driven genomic and clinical data intelligence platform company, today announced the launch of Sema4 Elements™, a portfolio of information-driven genomic solutions, digital tools for patients ...
GlobeNewswire · 09/09 12:00
Sema4 to Participate at Two Upcoming Investor Conferences in September
STAMFORD, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, Ph.D., Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Offic...
GlobeNewswire · 08/30 20:05
Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights
85% test-volume growth (excluding COVID-19 tests) compared to same period in 2020 Recorded 56% growth in total revenue of $46.9 million Expanded health system partnerships to include NorthShore University, AdventHealth, and Avera Health Commitment to 2023 ...
GlobeNewswire · 08/16 20:05
Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
Avera Health, an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4, a patient-centered health intelligence company, today announced a new collaboration launching a precision medicine initiative. This initi...
GlobeNewswire · 08/11 12:00
UPDATE 1-Keith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln deal
reuters.com · 08/06 11:21
Keith Meister, Eli Casdin's third SPAC to merge with biotech EQRx
reuters.com · 08/06 11:03
Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced it will release financial results for the second quar...
GlobeNewswire · 08/02 13:00
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SMFRW. Analyze the recent business situations of Sema4 Holdings Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About SMFRW
Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user’s baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user’s baby health by screening childhood diseases.

Webull offers kinds of Sema4 Holdings Corp stock information, including NASDAQ:SMFRW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMFRW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SMFRW stock methods without spending real money on the virtual paper trading platform.